36 Spam-Free Article(s) Found
https://www.zacks.com/stock/news/2199886/4-etf-areas-stocks-to-win-on-upbeat-november-retail-sales?cid=CS-ZC-FT-etf_news_and_commentary-2199886
Dec 19, 2023 - Retail Sales in the United States increased 4.1% year-on-year in November 2023, marking the strongest annual growth since February, following a downwardly revised 2.2% gain in October.
zc:-8981531995955084045
0
https://www.zacks.com/stock/news/2210833/procter-gamble-pg-earnings-expected-to-grow-what-to-know-ahead-of-next-week-s-release?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-2210833
Jan 16, 2024 - P&G (PG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
zc:-5904597574393015460
0
https://www.zacks.com/stock/news/2214322/procter-gamble-pg-beats-q2-earnings-estimates-ups-eps-view?cid=CS-ZC-FT-analyst_blog|earnings_article-2214322
Jan 23, 2024 - Procter & Gamble's (PG) Q2 results reflect robust pricing, along with growth across all segments. All its business segments have seen growth in organic sales.
zc:191133150148406741
0
https://www.zacks.com/stock/news/2214313/q4-earnings-for-j-j-procter-ge-more?cid=CS-ZC-FT-ahead_of_wall_street-2214313
Jan 23, 2024 - Pre-market trading fortunes are mixed for this morning's reportees, including JNJ, PG, GE, MMM and DHI.
zc:-1594120432798732498
0
https://www.zacks.com/commentary/2232353/top-analyst-reports-for-eli-lilly-procter-gamble-morgan-stanley?cid=CS-ZC-FT-research_daily-2232353
Feb 27, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
zc:-4727743462274195510
0
https://www.zacks.com/stock/news/2253885/wall-street-analysts-see-p-g-pg-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2253885
Apr 11, 2024 - Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
zc:-6760578360070056893
0